Chief, Division of Genetics and Genomics, Boston Children’s Hospital
Bullard Professor of Pediatrics and Neurology at Harvard Medical School
Investigator, Howard Hughes Medical Institute
Director and co-PI, Allen Discovery Center for Human Brain Evolution
Associate Member, Broad Institute of MIT and Harvard
Dr.
Walsh completed his MD and PhD degrees at The University of Chicago, neurology
residency and chief residency at Massachusetts General Hospital, and
postdoctoral training in Genetics with Professor Connie Cepko at Harvard
Medical School. In 1993 he became Assistant Professor of Neurology at
Harvard and Beth Israel-Deaconess Medical Center and was promoted to Bullard
Professor of Neurology in 1999. In 2002 he was appointed an Investigator of the
Howard Hughes Medical Institute. From 2003-2007 he served as
Director of the Harvard-MIT Combined MD-PhD training program. He moved to Boston
Children’s Hospital in 2006, becoming
Chief of Genetics, which in 2014 merged with the Program in Genomics to become
the Division of Genetics and Genomics. The Division contains more than
thirty full-time faculty members, roughly evenly divided between clinicians
treating children with rare genetic disease, and researchers studying the
genetic causes of human illness.
Dr.
Walsh’s research has focused on the development and function of the human
cerebral cortex, pioneering the analysis of genetic diseases that affect the
developing brain, resulting in epilepsy, intellectual disability, autism
spectrum disorders, and other conditions. His lab has identified more than
three dozen neurological disease genes by establishing world-wide collaborations
and pioneering the analysis of recessive brain disorders in countries where
marriage between distant relatives is common. He has described how a few
disease genes essential for constructing the brain were also important targets
of the evolutionary processes that shaped the human brain, resulting in the
founding of the Allen Discovery Center for Human Brain Evolution in 2017. Recent
work has pioneered the understanding of clonal somatic mutations as important
causes of human focal epilepsy and autism, and the remarkable genomic diversity
of single neurons in human brain.
Dr.
Walsh’s research has been recognized by a Javits Award from the NINDS, the Dreifuss-Penry Epilepsy Award from the American
Academy of Neurology, the Derek Denny-Brown and Jacoby Awards from the American
Neurological Association, the Clinical Research Award from the American
Epilepsy Society, the Pruzhansky Award from the American College of Medical
Genetics, the Cajal Club Discoverer Award, the Perl-Neuroscience Award from the
University of North Carolina, the Distinguished Alumni Award from the
University of Chicago, and the Gruber Neuroscience Prize in 2021. Dr.
Walsh is an elected fellow of the American
Association for the Advancement of Sciences, and an elected member of the
American Association of Physicians, the National Academy of Medicine, the American
Academy of Arts and Sciences, and the National Academy of Sciences.
Chief, Division of Genetics and Genomics, Boston Children’s Hospital
Bullard Professor of Pediatrics and Neurology at Harvard Medical School
Investigator, Howard Hughes Medical Institute
Director and co-PI, Allen Discovery Center for Human Brain Evolution
Associate Member, Broad Institute of MIT and Harvard
Dr.
Walsh completed his MD and PhD degrees at The University of Chicago, neurology
residency and chief residency at Massachusetts General Hospital, and
postdoctoral training in Genetics with Professor Connie Cepko at Harvard
Medical School. In 1993 he became Assistant Professor of Neurology at
Harvard and Beth Israel-Deaconess Medical Center and was promoted to Bullard
Professor of Neurology in 1999. In 2002 he was appointed an Investigator of the
Howard Hughes Medical Institute. From 2003-2007 he served as
Director of the Harvard-MIT Combined MD-PhD training program. He moved to Boston
Children’s Hospital in 2006, becoming
Chief of Genetics, which in 2014 merged with the Program in Genomics to become
the Division of Genetics and Genomics. The Division contains more than
thirty full-time faculty members, roughly evenly divided between clinicians
treating children with rare genetic disease, and researchers studying the
genetic causes of human illness.
Dr.
Walsh’s research has focused on the development and function of the human
cerebral cortex, pioneering the analysis of genetic diseases that affect the
developing brain, resulting in epilepsy, intellectual disability, autism
spectrum disorders, and other conditions. His lab has identified more than
three dozen neurological disease genes by establishing world-wide collaborations
and pioneering the analysis of recessive brain disorders in countries where
marriage between distant relatives is common. He has described how a few
disease genes essential for constructing the brain were also important targets
of the evolutionary processes that shaped the human brain, resulting in the
founding of the Allen Discovery Center for Human Brain Evolution in 2017. Recent
work has pioneered the understanding of clonal somatic mutations as important
causes of human focal epilepsy and autism, and the remarkable genomic diversity
of single neurons in human brain.
Dr.
Walsh’s research has been recognized by a Javits Award from the NINDS, the Dreifuss-Penry Epilepsy Award from the American
Academy of Neurology, the Derek Denny-Brown and Jacoby Awards from the American
Neurological Association, the Clinical Research Award from the American
Epilepsy Society, the Pruzhansky Award from the American College of Medical
Genetics, the Cajal Club Discoverer Award, the Perl-Neuroscience Award from the
University of North Carolina, the Distinguished Alumni Award from the
University of Chicago, and the Gruber Neuroscience Prize in 2021. Dr.
Walsh is an elected fellow of the American
Association for the Advancement of Sciences, and an elected member of the
American Association of Physicians, the National Academy of Medicine, the American
Academy of Arts and Sciences, and the National Academy of Sciences.
Journal article
The ADAT2/ADAT3 (ADAT) complex catalyzes the adenosine to inosine modification at the wobble position of eukaryotic tRNAs. Mutations in ADAT3, the catalytically inactive subunit of the ADAT2/ADAT3 complex, have been identified in patients presenting with severe neurodevelopmental disorders. Yet, the physiological function of ADAT2/ADAT3 complex during brain development remains totally unknown. Here, we investigated the role of the ADAT2/ADAT3 complex in cortical development. First, we reported...
Journal article
Amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer's disease (AD) are common neurodegenerative disorders for which the mechanisms driving neuronal death remain unclear. Single-cell whole-genome sequencing of 429 neurons from three C9ORF72 ALS, six C9ORF72 FTD, seven AD, and twenty-three neurotypical control brains revealed significantly increased burdens in somatic single nucleotide variant (sSNV) and insertion/deletion (sIndel) in all three disease conditions....